BioSpace News Archive

Moberg Pharma Reorganizes its Commercial Operations

A global Consumer Health unit will be established to manage Moberg’s direct and distributor sales. Jeff Vernimb, currently General Manager North America, has been appointed VP Global Consumer Health.

November 30, 2017

·

2 min read

Business

Celebrity Trainer and Author Bob Harper Teams up With AstraZeneca to Connect With Fellow Heart Attack Survivors

Bob Harper and AstraZeneca are asking those who have had a heart attack to visit www.survivorshaveheart.com and submit an essay of 500 words or less about their experience and recovery.

November 30, 2017

·

7 min read

Biotech Beach

Glaukos Announces Issuance of New U.S. Patent

The newly issued patent covers ocular devices and methods of surgically implanting the devices at least partially within Schlemm’s canal to facilitate the flow of aqueous humor.

November 30, 2017

·

6 min read

Biotech Bay

Data From BioTime’s Renevia Program to Be Presented at IFATS Conference

The Renevia program will be presented by primary investigator Ramon Llull, MD, PhD, Director of Stem Europe Mallorca Center, Mallorca, Spain at the “Plenary Session 2 - Clinical Studies with SVF”.

November 30, 2017

·

2 min read

Business

Acerus Secures CDN$1.6M of New NATESTO Orders from Its U.S. Licensee Aytu Bioscience

As per the terms of the License and Supply Agreement with Aytu, revenues associated with these orders will be recognized on delivery of the product to Aytu, with additional revenues recognized quarterly based on a percentage of net sales.

November 30, 2017

·

7 min read

Drug Development

New and Updated Data for Merck’s KEYTRUDA (pembrolizumab) and Updated Data on LYNPARZA (olaparib) in Multiple Breast Cancer Subtypes to Be Presented at the 2017 San Antonio Breast Cancer Symposium (SABCS)

In addition to the presentation of KEYTRUDA data at SABCS, updated data on LYNPARZA being co-developed and co-commercialized with AstraZeneca, will be presented.

November 30, 2017

·

33 min read

Nuvo Pharma Announces Normal Course Issuer Bid

The normal course issuer bid will be made in accordance with the requirements of the TSX.

November 30, 2017

·

4 min read

Cyclica Launches Ligand Express, a Disruptive Cloud-Based Platform to Revolutionize Drug Discovery

The unique platform, which harnesses biophysics, biological data, and AI, is actively being used by pharmaceutical scientists to more efficiently navigate the drug discovery pipeline.

November 30, 2017

·

2 min read

Drug Development

Solid Biosciences Initiates Clinical Trial for Gene Transfer Candidate SGT-001 in Patients With Duchenne Muscular Dystrophy

Interim analysis anticipated in the first half of 2019.

November 30, 2017

·

5 min read

Genetown

Enanta Announces That AbbVie’s MAVIRET (glecaprevir/pibrentasvir) Is Now Available in Japan for the Treatment of Chronic Hepatitis C Across All Major Genotypes (GT1-6)

With the reimbursement approval in Japan, Enanta has now earned a $15 million milestone payment, which it expects to receive this quarter.

November 30, 2017

·

5 min read